Company Announcements

Issue of Equity

Source: RNS
RNS Number : 0656X
RIT Capital Partners PLC
17 December 2019
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

 

17 December 2019

 

ISSUE OF EQUITY

 

The Board of RIT Capital Partners plc (the "Company") announces that 1,496,634 new ordinary shares (the "Shares") are being issued as consideration for the Company's investment in the Technology Investment Banking Advisory business of LionTree, a differentiated global investment and merchant banking firm for companies in the creative digital economy. The Shares are being issued at a premium to the Company's net asset value and will rank pari passu with the existing ordinary shares in issue, including for all dividends declared after admission.

 

Application has been made to the Financial Conduct Authority and to the London Stock Exchange for the admission of the Shares to the Official List and to trading on the Main Market of the London Stock Exchange.  Admission and closing is expected to take place on or around 20 December 2019.  

 

ABOUT LIONTREE

LionTree is a differentiated global investment and merchant banking firm for companies in the creative digital economy. Founded in 2012, LionTree works across offices in New York, San Francisco, London and Paris to serve clients on transactions around the globe. The Firm leverages its unique insights and relationships across its integrated product set: M&A Advisory, Capital Raising, IPO Advisory, Merchant Banking, Institutional Investor Membership and LT Growth. Across these focus areas the firm connects clients with tailored ideas, actionable opportunities and resources that drive results. Kindred, LionTree's digital media solutions company, allows LionTree's network to stay up to date on LionTree's news and announcements while connecting with the community of clients.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOECKADQKBDBABD